Three patients enrolled in Juno Therapeutics' cancer trial have died, leading the US Food and Drug Administration to halt the study, Forbes reports. The patients died of cerebral edema.
Three patients enrolled in Juno Therapeutics' cancer trial have died, leading the US Food and Drug Administration to halt the study, Forbes reports. The patients died of cerebral edema.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.